Results 281 to 290 of about 120,747 (306)

GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Cells, 2023
Ka Young Kim, Keun-A Chang, Chang Keun-A   +2 more
exaly  

INCREASES IN GFAP AND GFAP mRNA IN BRINDLED MOUSE CNS.

Journal of Neuropathology and Experimental Neurology, 1987
B. Shafit-Zagardo, C. Peterson, J. E. Goldman   +2 more
openaire   +1 more source

GFAP

1998
Tak W. Mak, Josef Penninger, John Roder, Janet Rossant, Mary Saunders   +4 more
openaire   +1 more source

GFAPδ: A Promising Biomarker and Therapeutic Target in Glioblastoma

Frontiers in Oncology, 2022
Roxana Radu, George E D Petrescu, Radu M Gorgan   +2 more
exaly  

GFAP Alternative Splicing and the Relevance for Disease – A Focus on Diffuse Gliomas

ASN Neuro, 2022
Jessy V Van Asperen, Pierre A Robe, Elly M Hol   +2 more
exaly  

GFAP cloned

Trends in Neurosciences, 1984
openaire   +1 more source

Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress

Redox Biology, 2022
Alvaro Viedma-Poyatos, Patricia Gonzalez-Jimenez, Maria A Pajarès   +2 more
exaly  

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

Brain, 2021
Joana B Pereira, Shorena Janelidze, Ruben Smith   +2 more
exaly  

GFAP antibody–negative myelitis with high similarity to autoimmune GFAP astrocytopathy: a case report

Neurological Sciences, 2022
Yi-Ming Zhang, Shen Liu, Ting-Ting Liu, Hong-Dong Zhao, Jian-Quan Shi   +4 more
openaire   +1 more source

Importance of GFAP isoform‐specific analyses in astrocytoma

Glia, 2019
Elly M Hol, Emma J Van Bodegraven, Jessy V Van Asperen   +2 more
exaly